Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication.
RNA interference as a tool for exploring HIV-1 robustness.
Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.
IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.
Minimal removal of raltegravir by hemodialysis in HIV-infected patients with end-stage renal disease.
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir.